(AAPG) Ascentage Pharma - Performance 81.3% in 12m
AAPG performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
41.58%
#12 in Peer-Group
Rel. Strength
94.39%
#428 in Stock-Universe
Total Return 12m
81.30%
#19 in Peer-Group
Total Return 5y
81.30%
#22 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 32.02 USD |
| 52 Week Low | 17.20 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 63.78 |
| Buy/Sell Signal +-5 | -1.07 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AAPG (81.3%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: AAPG vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AAPG
| Total Return (including Dividends) | AAPG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 39.70% | 7.76% | 1.11% |
| 3 Months | 60.11% | -5.31% | 5.58% |
| 12 Months | 81.30% | -7.58% | 10.51% |
| 5 Years | 81.30% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | AAPG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 91.7% | 84.2% | 69.9% |
| 3 Months | 82.5% | -2.8% | 69.3% |
| 12 Months | 86.2% | -77.8% | 43.2% |
| 5 Years | 86.2% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #21 | 29.64% | 38.17% |
| 3 Month | #6 | 69.08% | 51.65% |
| 12 Month | #16 | 100.50% | 84.08% |
| 5 Years | #22 | 100.50% | 84.08% |
FAQs
Does Ascentage Pharma (AAPG) outperform the market?
Yes,
over the last 12 months AAPG made 81.30%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months AAPG made 60.11%, while XBI made -5.31%.
Performance Comparison AAPG vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AAPG vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.9% | 38.6% | 82.3% | 71% |
| US NASDAQ 100 | QQQ | 6.2% | 38.2% | 83.1% | 72% |
| German DAX 40 | DAX | 8.1% | 40.5% | 66% | 52% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.2% | 40.6% | 80.5% | 70% |
| Hongkong Hang Seng | HSI | 5.4% | 34.7% | 63.3% | 54% |
| India NIFTY 50 | INDA | 7.6% | 41% | 83.3% | 83% |
| Brasil Bovespa | EWZ | 3.6% | 39.2% | 62.1% | 72% |
AAPG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.3% | 38.2% | 79.5% | 59% |
| Consumer Discretionary | XLY | 6.5% | 41.5% | 92.2% | 64% |
| Consumer Staples | XLP | 6.2% | 39.9% | 80.8% | 74% |
| Energy | XLE | 0% | 36.8% | 78.7% | 78% |
| Financial | XLF | 7.5% | 42.3% | 79.5% | 58% |
| Health Care | XLV | 4% | 35.4% | 82.8% | 86% |
| Industrial | XLI | 6.9% | 39.4% | 76.8% | 63% |
| Materials | XLB | 6.6% | 38.3% | 81.5% | 82% |
| Real Estate | XLRE | 5.4% | 38.7% | 81.3% | 68% |
| Technology | XLK | 5.6% | 37.7% | 81.9% | 77% |
| Utilities | XLU | 4.5% | 39.2% | 74% | 60% |
| Aerospace & Defense | XAR | 6.9% | 33.9% | 65.4% | 39% |
| Biotech | XBI | 6.3% | 31.9% | 93.1% | 89% |
| Homebuilder | XHB | 7.5% | 44.7% | 97.7% | 91% |
| Retail | XRT | 9.8% | 39.9% | 90.3% | 81% |
AAPG vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.9% | 21.0% | 72.5% | 78% |
| Natural Gas | UNG | 6.7% | 42.3% | 64% | 96% |
| Gold | GLD | 2.3% | 33.5% | 52.1% | 34% |
| Silver | SLV | 6.7% | 28.4% | 62.7% | 59% |
| Copper | CPER | 8.4% | 38% | 67.4% | 73% |
AAPG vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.4% | 39% | 83.7% | 85% |
| iShares High Yield Corp. Bond | HYG | 5.4% | 39.2% | 78.6% | 72% |